diabetics, who appeared to have lost the usual 'protection' from coronary disease experienced by female non-diabetics. This is the usual experience in other studies, with the sole reported exception of Warsaw (Krolewski et al. 1977) where diabetic women had an increased risk similar to that of male diabetics.
Some of the increased mortality amongst diabetics may be due, in addition to a greater frequency of cardiac infarction, to a greater risk of dying in the acute stage of an infarct. Reports before (Jarrett, 1961; Honey & Truelove, 1957) and since (Soler et al. 1974; Harrower & Clarke, 1976 ) the advent of coronary care units have demonstrated a greater hospital mortality in diabetics. Some of this may be attributed to the precipitation of ketoacidosis by the infarct (Bradley & Bryfogle, 1956) . Other possibly deleterious factors include pre-existing disease of the fine divisions of the coronary arteries (Ledet, 1976 ) and depletion of cardiac noradrenaline stores in the hearts of long-standing diabetics (Christensen, 1979) .
The term 'diabetic cardiopathy' has been introduced to embrace diverse cardiac abnormalities in the diabetic not attributable to atherosclerosis or valvular disease. A number of histopathological abnormalities have been described in autopsy studies and in vivo measurements, using echocardiography and other techniques, have demonstrated subclinical myocardial dysfunction in diabetics. Some of the abnormalities are reversible by improved blood glucose control (Sykes et al. 1977) . There is, as yet, insufficient information to allow an estimate of the contribution made by 'diabetic cardiopathy' to cardiac mortality and morbidity in diabetics. However, in the Framingham study the occurrence of congestive cardiac failure was more frequent in insulin requiring diabetics and this could not be explained by co-existing, overt coronary heart disease.
The increased arterial disease risk for diabetics is most obvious in countries where atherosclerosis is common in the general population. In countries, such as Japan, where atherosclerosis is relatively uncommon and mortality from coronary heart disease is low (Keys (editor), 1970), mortality is also relatively low in diabetics. Nevertheless, in a large autopsy study, myocardial infarction was found twice as frequently in Japanese diabetics compared with non-diabetics (Goto, 1978) . The low rate of coronary heart disease in Japan is not due to ethnic factors, for Japanese migrants to Hawaii and California have rates of CHD similar to North Americans in general (Kawate et al. 1978 ) and CHD is increasing in Japan itself (Sasaki et al. 1978) . Apart from the Japanese, there are other ethnic groups reported to have low or very low rates of CHD, both amongst diabetics and nondiabetics (see Jarrett & Keen, 1975) . My interpretation of the epidemiological observations is that atherosclerotic disease in the diabetic responds to the same environmental determinants as that in the non-diabetics, albeit with some 'amplification'. What the amplifying factors are remains a subject for debate.
Risk indices for coronary heart disease in diabetics
There is some controversy over the relative prevalence in diabetic and nondiabetic populations of such well known indicators of risk as hypertension, lipoprotein cholesterol levels and cigarette smoking (see Jarrett & Keen, 1975) .
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Nutrition and diabetes 21 I Different studies have given different answers and it is not known how much of these differences is real or how much is due to bias in sampling, both of diabetics and non-diabetics. A further problem in analysis is a general failure in most studies to differentiate between insulin dependent and non-insulin dependent diabetics, who differ in many respects, though not in their propensity to atherosclerosis.
In the Framingham Study (Garcia et al. 1974; Gordon et al. 1977) multivariate analysis was used to examine the predictive power of several conventional risk indices for CHD (mortality plus morbidity) in the diabetics of that population. While the usual risk indices gave some degree of prediction, they were insufficient to account for the excess arterial disease rates in the diabetics. Similarly, in the Whitehall Study, a prospective study of male Civil Servants (Reid et al. 1974) , known and newly found diabetics had similar CHD death rates 7.5 years after initial observation, which were twice those of the non-diabetics studied, although mean values of blood pressure, serum cholesterol and cigarette consumption, were almost identical in all three groups (R. J. Jarrett, unpublished results).
Obesity
There can be no doubt that obesity is the major environmental factor in determining the prevalence of non-insulin dependent diabetes in a population. A great many studies support this. On an international scale, the epidemiological studies of West & Kalbfleisch (1971) in ten populations yielded a high degree of correlation between diabetes prevalence (above the age of 35 years) and 'average fatness'. A more dramatic illustration of the association is the relatively recent appearance of diabetics in almost epidemic proportions in several populations, the two most notable being the Pima Indians in Arizona (Hamman et al. 1978 ) and the population of the Pacific Island of Nauru (Zimmet & Taft, 1978) .
Any link between obesity in diabetics and atherosclerosis, however, is much less obvious. Firstly, obesity is not a notable feature amongst insulin-dependent diabetics, who, nevertheless, are at greater risk of arterial disease. Secondly, prospective studies have failed to show any predictive power for obesity when other factors linked to obesity, such as levels of blood pressure and serum lipids, are allowed for in the multivariate statistical analysis (Gordon et al. 1977; R. J. Jarrett, unpublished results) . In the frequently quoted UGDP Study (University Group Diabetes Program, 1970) mortality rates from cardiovascular disease were actually less in recruits to the trial with the higher relative body-weights.
Several other prospective studies have also failed to show any specific effect of obesity upon cardiovascular mortality rates in diabetics. These include the actuarial study in Birmingham, England (Hayward & Lucena, 1965 ) and the study of diabetics working for the Dupont Corporation in the USA (Pell & D'Alonzo, Thus, while obesity pre-disposes to the development of non-insulin dependent diabetes and while this and insulin-dependent diabetes pre-dispose to atherosclerosis and clinical arterial disease, there is little to suggest that obesity can explain the enhanced risk of arterial disease. Nor, despite the theoretical 1970).
https://www.cambridge.org/core/terms. https://doi.org/10.1079/PNS19810030 benefits of reduced blood pressure and serum cholesterol level achieved by substantial weight loss, can we point to demonstrable evidence of a reduction in arterial disease, morbidity or mortality in successful diabetic slimmers.
